United States · FDA National Drug Code directory
Curosurf
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-510_6b713a41-2648-43f4-9a10-cc41a7e83ca0
- Product NDC
- 10122-510
- Form
- SUSPENSION
- Composition / generic term
- poractant alfa
- Labeler
- Chiesi USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 19991118
- Source listing expiry
- 20261231
Source-listed ingredients
- PORACTANT ALFA — 80 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1.5 mL in 1 VIAL, GLASS (10122-510-01) · 10122-510-01
- 3 mL in 1 VIAL, GLASS (10122-510-03) · 10122-510-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →